Skip to content

Harmony Biosciences Holdings, Inc. HRMY Total Non-Current Liabilities

Total Non-Current Liabilities at other companies

Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$7.59M-37.4%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$2.77B+18.0%

Other financials

Income statement

See full
Revenue$215.4M+16.6%
Gross profit$170.9M+11.9%
Operating income$37.3M-33.7%
Net income$32.5M-28.7%
EPS (diluted)$0.55-29.5%

Balance sheet

See full
Cash & equivalents$589.4M+20.5%
Total debt$164.6M-7.2%
Total equity$910.3M+26.3%
Total assets$1.3B+20.5%

Cash flow

See full
Operating cash flow$27.8M-18.3%
CapEx$107.0K-79.1%
Free cash flow$126.0M+67.9%

Valuation

See full
Market cap$1.98B-14.9%
Enterprise value$1.55B-24.9%
P/E13.6×-1.6×
P/S2.2×-0.9×

Profitability

See full
Gross margin76.5%-1.8pp
Operating margin21.1%-5.1pp
Net margin16.2%-4.3pp
FCF margin40.1%+9.5pp

Returns & leverage

See full
Return on equity17.9%-6.9pp
Debt / equity0.2×-0.1×
Current ratio3.6×-0.1×

Where this comes from

Reported directly by Harmony Biosciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesNoncurrent.

The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harmony Biosciences Holdings, Inc.'s total non-current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harmony Biosciences Holdings, Inc.'s total non-current liabilities?
Harmony Biosciences Holdings, Inc. (HRMY) reported total non-current liabilities of $144.14M in Q1 2026.
How has Harmony Biosciences Holdings, Inc.'s total non-current liabilities changed year-over-year?
Harmony Biosciences Holdings, Inc.'s total non-current liabilities decreased by 9.9% year-over-year, from $159.89M to $144.14M.
What is the long-term trend for Harmony Biosciences Holdings, Inc.'s total non-current liabilities?
Over 5 years (2020 to 2025), Harmony Biosciences Holdings, Inc.'s total non-current liabilities has grown at a -5.2% compound annual growth rate (CAGR), from $195.36M to $149.28M.
What does total non-current liabilities mean?
The sum of all long-term obligations due beyond one year — long-term debt, lease liabilities, pension obligations, and deferred items.